Metformin: Should it be the first therapeutic option in the patient with high-risk diabetes?

pp. 58-64

Authors

  • Hugo Daniel Sanabria Chair of the Diabetes Clinic of Instituto Cardiovascular de Buenos Aires. Former Chair of the Cardiometabolic Council of the Argentine Society of Cardiology https://orcid.org/0000-0002-5600-2617
  • Augusto Lavalle Cobo Coordinator of the Cardiology Department, Sanatorio Finochietto – Former Head of SAC Cardiovascular Epidemiology and Prevention Council https://orcid.org/0000-0002-1257-9211

DOI:

https://doi.org/10.7775/rac.es.v89.i1.19784

Abstract

  

Downloads

Published

2025-04-15

Issue

Rev Argent Cardiol 2021 Issue 89 Nro. 1

Section

CONTROVERSIAS

License

Copyright (c) 2025 Argentine Journal of Cardiology

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)